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HRLICH demonstrated that basic but not acidic dyes are capable of crossing cerebral capillaries, and that entry into the brain from blood is determined by "chemical affinity" for the blood-brain barrier. The biochemical criteria necessary for blood constituents to traverse a normal blood-brain barrier are complex, and include lipid solubility, molecular charge, size, and weight, membrane permeability coefficients, diffusion, and osmotic and transport properties. The precise properties required for molecular passage through neoplastic brain capillaries are unknown. The detection of soluble blood-group antigens (SBGA) and antibodies in human brain-tumor cysts is potentially useful to further delineate the biochemical requirements necessary for molecular permeation from peripheral blood into brain-tumor cysts. Soluble blood-group antigens have been found in abundance in human pseudomucinous ovarian cysts and hydatid cysts, and these fluids have provided an excellent source for the immunochemical characterization of SBGA. "'1~ Moreover, blood-group antibody studies may provide information regarding the immune response to certain human neoplasms. Levine, 7 for example, demonstrated the presence of anti-Tj, in a patient who was homozygous for the "pp" blood-group antigens, and who had an adenocarcinoma of the stomach. This antibody, later shown to bind to a tumorspecific surface antigen on the adenocarcinoma cells, has been referred to as an "illegitimate blood-group antigen" since it should not have occurred in a patient homozygous for the "pp" erythrocyte antigen. We have recently demonstrated that human brain-tumor cysts which occur in malignant cerebral astrocytomas and benign cerebellar hemangioblastomas have a high content of immunoglobulins IgG and IgA with low IgM levels. TM In the present study, Le b *Oligo = oligodendroglioma; H = hemangioblastoma; AI-IV = Grades I-IV astrocytomas; F, P, T, and C = frontal, parietal, temporal, and cerebellar lobes, respectively; NT = specimen available but not tested; NA = specimen not available for testing; H, A, B, Le% and Le b are abbreviations for H, A, B, and Lewis~ and Lewis b soluble blood-group substances (antigens), respectively. tAI indicates Grade I astrocytoma as the operative diagnosis, while the surgical specimen was read as gliosis by the neuropathologist. These patients were diagnosed clinically as brain-tumor patients with Grade I astrocytoma.
we have delineated the immunoglobulin class of blood-group antibodies and the presence of SBGA within such cysts and further characterized the requirements necessary for penetration through altered blood-brain barriers of certain brain-tumor cysts.
Materials and Methods

Materials
Tumor cyst fluids from eight patients with malignant cerebral astrocytomas, three patients with benign cerebellar hemangioblastomas, and one patient with a cerebral oligodendroglioma were obtained at surgery, centrifuged for 10 minutes at 1200 rpm, and subsequently stored at -70 ~ C for further analysis. Except for samples from Cases 5 and 6 (Table 1) , all cysts were crystal clear upon collection and were free of erythrocytes after centrifugation. Where possible, saliva, serum, cyst fluid, and cerebrospinal fluid (CSF) were collected, centrifuged, and stored at -70~
Determination of Isohemagglutinins and Soluble Blood-Group Antigens
Reference erythrocytes and monospecific antisera (anti-A, B, H, and Lewis) to human blood-group antigens were obtained from Spectra Biologicals.* Tests for SBGA were evaluated using twofold dilutions of normal saline at 37 ~ C for 30 minutes coupled with neutralization techniques to determine the presence or absence of hemagglutination.' Soluble blood-group antigens (Table 1) were considered to be present when two tube differences for dilution titers were observed between controls and experimental samples.
Isohemagglutinins were determined by incubating appropriate ABO human red cells with the fluids to be tested (Table 2) . Two percent reference erythrocytes were incubated for 30 minutes at room temperature with sample unknowns, and subsequently observed for hemagglutination. End-point titers were recorded and compared with saline controls. The presence of anti-A and anti-B bloodgroup antibodies were determined for serum, cyst fluid, and CSF specimens.
Secretor Status
Saliva specimens were collected and subsequently boiled in a water bath for 10 minutes in order to remove debris and *Human blood-group antigens were obtained from Spectra Biologicals, Becton, Dickinson and Co., Oxnard, California. proteolytic enzymes, which may inactivate salivary SBGA? After they were boiled, samples were centrifuged for 10 minutes at 1200 rpm and supernatants analyzed for the presence of SBGA as described above.
Immunoglobulin Analysis of Isohemagglutinins
Differentiation between IgM and IgG blood-group antibodies (Table 3) was achieved by incubating equal volumes of sera and cyst fluids with dithiothreitol (DTT) at 37 ~ C for 30 minutes, x3 Twofold dilutions were prepared with DTT and results compared with nontreated control titers. All samples were incubated with reference blood cells (2%) for 30 minutes at room temperature. End-point titers were determined using a hand magnification lens and observing for hemagglutination after 15 seconds centrifugation.
Results
The clinical data for the patients studied are presented in Table 1 . The incidence of males and females was similar and the ages ranged from 16 to 79 years. Of the 12 braintumor cysts studied, eight were derived from malignant cerebral astrocytomas, three from benign cerebellar hemangioblastomas, and one from an oligodendroglioma. Cases 2 and 3 had the intraoperative diagnosis of astrocytoma, while the neuropathological diagnosis of the surgical specimen was "gliosis." Astrocytoma cyst fluids were from all grades of astrocytomas, I-IV? None of the patients received blood transfusions before the sampiing period. Approximately 50% of the patients studied were Rho negative.
The results of SBGA studies on autologous samples of saliva, serum, cyst fluid, and CSF are shown in Table 1 . Where saliva was available, serum was not always tested for SBGA since the presence of these substances in serum is dictated by salivary secretor status.
Anti-A and anti-B blood-group antibodies were present in cyst fluids of nine of the nine patients studied. All cyst fluid blood-group antibody titers were lower than serum values (Table 2 ) and were not detected in any of four CSF specimens.
The studies of the immunoglobulin class of blood-group antibodies found in human brain-tumor cysts and sera are summarized in Table 3 . The titer values for DTT inactivation of IgM blood group antibodies demonstrated that blood-group antibodies in these fluids may be either IgG or IgM.
Discussion
Soluble blood-group antigens and antibodies do occur within cyst fluids derived from certain astrocytomas, hemangioblastomas, and oligodendrogliomas. Antibodies to blood groups A and B are present in these cysts and may be IgG or IgM. Soluble blood group substances, A and B, are glycoproteins 5 or glycolipids, 15 and were detected in three of four malignant cerebral astrocytomas and one oligodendroglioma cyst fluid. Lewis a (Le a) was demonstrated in cyst fluid of one of three benign cerebellar hemangioblastomas studied. Failure to detect SBGA in CSF is not necessarily indicative of absence of these constituents in spinal fluid, since the latter normally contains low total protein and immunoglobulin in comparison to serum. Therefore, the absence of SBGA in CSF may reflect the limitations of the assay employed. After repeated testing, we were able to detect Lewis b (Le b) in the CSF of one patient (Case 12). Lewis b could occur in the CSF if serum Le b permeated an abnormal blood-CSF barrier secondary to the destructive action of brain tumor.
Blood-group antibodies are naturally occurring, and are IgM and/or IgG immunoglobulins) Titer values for blood-group antibodies in all cyst fluids were lower than those of autologous sera. Determinations of three of four cyst fluids demonstrated that immunoglobulin classes corresponded to those of sera. Cyst fluid from the patient in Case 2, however, contained blood-group antibodies of the IgG class, while her serum antibodies were IgM. This finding is consistent with the results from our previous quantitative immunoprotein studies, which demonstrated that the cyst fluid IgG values were much higher than IgM levels. TM Soluble blood-group antigens A or B were detected in five of five sera and in three of five corresponding tumor cysts. We believe that the soluble blood-group substances that occur in cyst fluids originate from plasma sources and not from neuroectodermal tissue for the following reasons: 1) the bulk of protein accumulation within primary brain-neoplasm cysts is a consequence of transudation from serum, TM and 2) isoantigens A, B, and H are not present (or readily detectable) in normal brain, or in benign or malignant brain-tumor tissues, but have been detected in the anterior lobe of pituitary glands?." Although brain parenchyma contains little or no detectable isoantigens, cerebral capillary endothelial cells in normal and certain neoplastic states have abundant blood-group antigens on their cell surfaces. 2 We cannot, therefore, exclude the possibility that soluble blood-group antigens found within the cyst fluids studied were not, at least in part, derived from endothelial cell sources.
Data from our previous protein studies on tumor fluids suggest that cyst formation in human brain-tumor cysts is secondary to a transudation of serum constituents through altered tumor cyst walls. TM Lewis a and Le b soluble blood-group antigens are fucolipids, *The DTT treated titers reduced the original concentration of blood-group antibody by 50 % so that a two-fold reduction in agglutination titers reflects simple dilution of antiserum. A greater than twofold reduction of titers, therefore, is indicative of IgM antibody inactivation. No reduction in titer was interpreted to represent the presence of IgG antibody. which differ by one fucose side chain, and are not known to occur within the central nervous system) We detected Le a but not Le b in four of 12 cyst fluids studied. The presence of SBGA A and B, which in serum are glycolipids, and Le a substance, a fucolipid, 8,8 within cyst fluids, the lower isohemagglutinin titers in cysts than serum, and the similarity between serum and cyst immunoglobulin class provide further supportive evidence that cyst formation within certain human brain tumors is consequential to a transudative process from serum.
More knowledge of the chemical contents of the cyst fluid that occurs in brain neoplasms is necessary to establish its potential significance and to further delineate the biochemical requirements necessary for molecular penetration into brain-tumor cysts.
